2013-11-15T14:17:31-06:00 2012-12-31 271728945 O'CONNOR DAVIES LLP 665 FIFTH AVENUE NEW YORK NY 10022 990 2012-01-01 223419667 INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE INC INTE 2125005724 61 BROADWAY NO 1720 NEW YORK NY 10006 JOSE LUIS CASTRO 2125005724 2013-11-15 1 GARRETT M HIGGINS P00543209 2122862600 2013-11-15 2012 2016-03-07 17:11:31Z THE UNION NORTH AMERICA JOSE LUIS CASTRO 61 BROADWAY NO 1720 NEW YORK NY 10006 18605126 0 X WWW.THEUNION.ORG X 1995 NJ THE UNION MISSION IS TO BRING INNOVATION, EXPERTISE, SOLUTIONS AND SUPPORT TO ADDRESS HEALTH CHALLENGES IN LOW- AND MIDDLE-INCOME POPULATIONS.VISIONHEALTH SOLUTIONS FOR THE POORVALUESQUALITY: WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST POSSIBLE STANDARDS. ACCOUNTABILITY: WE ARE RESPONSIBLE STEWARDS OF RESOURCES AND DELIVER ON OUR COMMITMENTS.INDEPENDENCE: WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION AND ARE GUIDED BY THE BEST EVIDENCE TO IMPROVE THE HEALTH OF THE POOR.SOLIDARITY: WE STAND TOGETHER AS ONE UNION TO OVERCOME THE GREATEST CHALLENGES TO IMPROVE HEALTH AMONG THE COMMUNITIES WE SERVE. 8 6 6 6 0 0 24925400 18600024 0 0 1246 5102 0 0 24926646 18605126 22613614 16670586 0 0 765501 760763 0 0 0 641815 1051328 24020930 18482677 905716 122449 9564646 6920720 8732417 5966043 832229 954677 X THE UNION BRINGS INNOVATION, EXPERTISE, SOLUTIONS AND SUPPORT TO ADDRESS HEALTH CHALLENGES IN LOW AND MIDDLE INCOME POPULATIONS. OUR VISION IS TO DEVELOP HEALTH SOLUTIONS FOR THE POOR. OUR VALUES INCLUDE:1. QUALITY: WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST POSSIBLE STANDARDS.2. ACCOUNTABILITY: WE ARE RESPONSIBLE STEWARDS OF RESOURCES AND DELIVER ON OUR COMMITMENTS.3. INDEPENDENCE: WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION, AND ARE GUIDED BY THE BEST EVIDENCE TO IMPROVE THE HEALTH OF THE POOR4. SOLIDARITY: WE STAND TOGETHER AS ONE UNION TO OVERCOME THE GREATEST CHALLENGES TO IMPROVE HEALTH AMONG THE COMMUNITIES WE SERVE. 0 0 13781615 13411880 TOBACCO CONTROL:OVERVIEW OF ACTIVITIES IN REPORTING PERIOD THROUGHOUT 2012, THE UNION HAS CONTINUED TO FOCUS ON WORKING WITH GOVERNMENTS, AT A NATIONAL LEVEL WHEREVER POSSIBLE, TO DEVELOP AND IMPLEMENT TOBACCO CONTROL LEGISLATION AND POLICY. COMPREHENSIVE TOBACCO CONTROL LEGISLATION WAS PASSED ARGENTINA, CHILE, VIETNAM AND BULGARIA. TOBACCO TAXATION LEGISLATION THAT WILL FUND TOBACCO CONTROL PROGRAMMES WAS PASSED IN THE PHILIPPINES. PROGRESS TOWARDS NATIONAL LEGISLATION HAS BEEN PROMISING IN BANGLADESH WHERE THE CABINET APPROVED A DRAFT TOBACCO CONTROL LAW AND IN CHINA WHERE TOBACCO CONTROL HAS BEEN INCLUDED ON THE TWELFTH FIVE-YEAR PLAN OF CHINA. WHERE NATIONAL PROGRESS IS SLOWER, STRATEGICALLY-SELECTED AND MULTILATERAL SUB-NATIONAL INITIATIVES ARE PROVING EFFECTIVE IN ADVANCING SMOKEFREE ENVIRONMENTS AND OTHER TOBACCO CONTROL MEASURES. THE CHINA SEVEN CITIES PROGRAMS AND THE INDONESIAN MAYORS ALLIANCE HAVE BOTH DEMONSTRATED THE POTENTIAL FOR SUB-NATIONAL COOPERATION ON SMOKEFREE ENVIRONMENTS TO PROTECT SIGNIFICANT POPULATIONS AND INFLUENCE THE NATIONAL AGENDA. BANGLADESH IS MOVING TOWARDS A SIMILAR MODEL AND HAS HAD MODEST SUCCESS IN KHULNA AND NARAYANGANJ CITIES.THE UNION CONTINUES TO FOCUS ON ESTABLISHING TOBACCO CONTROL INFRASTRUCTURES - SUCH AS GOVERNMENT TOBACCO CONTROL CELLS THAT CAN GRADUALLY BECOMING SELF-SUSTAINING THROUGH TOBACCO TAXATION ALLOCATIONS. THE GOVERNMENTS OF HARBIN, TIANJIN, SHENZHEN AND GUANGZHOU HAVE ALL ALLOCATED FUNDS TO TOBACCO CONTROL PROGRAMS AND CELLS. THE PHILIPPINES ESTABLISHED A NATIONAL TOBACCO CONTROL COORDINATING OFFICE (NTCCO) WITHIN THE DEPARTMENT OF HEALTH IN 2011.BUILDING ON THE UNION'S LONG HISTORY WITH PUBLIC HEALTH AND MEDICAL INSTITUTIONS AROUND THE WORLD, THE UNION IS CONTINUING TO ADVANCE TOBACCO CONTROL MEASURES THROUGH THE BROADER HEALTHCARE COMMUNITY. IN RUSSIA, THE UNION'S COLLABORATION WITH THE MINISTRY OF HEALTH RESULTED IN A SMOKING STATUS SECTION BEING INCLUDED IN THE ELECTRONIC PERSONAL MEDICAL HISTORY FOR GOVERNMENT HEALTHCARE PATIENTS. IN INDIA, THE UNION AND MINISTRY OF HEALTH HEALTH WORKERS GUIDE HAS BEEN DISTRIBUTED TO OVER HALF A MILLION FRONT-LINE HEALTH WORKERS OVER THE TWO YEAR PERIOD.INCREASINGLY, THE TOBACCO INDUSTRY IS RECOGNISING THE PROGRESS OF THE UNION AND PARTNERS, AND STEPPING UP EFFORTS TO COUNTER TOBACCO CONTROL PROGRAMS. THE UNION IS SUPPORTING BI GRANTEES TO DEFEND LEGISLATIVE CHALLENGES AND DEVELOPING MATERIALS - SUCH AS THE UNION FCTC ARTICLE 5.3 TOOLKIT - THAT WILL HELP GOVERNMENTS AND ORGANIZATIONS SAFEGUARD THEMSELVES FROM TOBACCO INDUSTRY INFLUENCE. THE UNION AND GRANTEES IN BRAZIL, INDIA, PAKISTAN, LEBANON AND SOUTH AFRICA HAVE SUCCESSFULLY DEFENDED CHALLENGES OR BROUGHT LEGAL PROCEEDINGS AGAINST THE TOBACCO INDUSTRY. 3796323 2965510 TREAT TB 2012 KEY ACCOMPLISHMENTS PROVE-IT:MANY NEW DIAGNOSTIC TOOLS FOR TB HAVE EMERGED RECENTLY, BUT THEIR PERFORMANCE IN DIVERSE EPIDEMIOLOGICAL SETTINGS, HEALTH SYSTEM STRUCTURES AND PATIENT GROUPS REMAINS UNCLEAR. IN AN EFFORT TO OPTIMIZE THE SCALE-UP OF THESE NEW DIAGNOSTIC TOOLS, TREAT TB HAS DEVELOPED AN ASSESSMENT METHODOLOGY THAT MOVES BEYOND THE TRADITIONAL ACCURACY TESTS TO EVALUATE A TOOL'S IMPACT ON BOTH THE HEALTH SYSTEM AND PATIENTS. UTILIZING THIS INNOVATIVE APPROACH, TREAT TB IS EVALUATING LINE PROBE ASSAYS (LPA), A NEW DIAGNOSTIC TEST THAT MAY MAKE RAPID SCREENING FOR DRUG-RESISTANT TB POSSIBLE. THE NAME OF THIS STUDY IS PROVE-IT (POLICY RELEVANT OUTCOMES FROM VALIDATING EVIDENCE ON IMPACT) AND IT AIMS TO IDENTIFY THE COSTS ASSOCIATED WITH LPA TESTS, THE PREREQUISITE HEALTH SYSTEM REQUIREMENTS, AND THE IMPACT ON THE TIME BETWEEN DIAGNOSIS AND TREATMENT.TREAT TB AND ITS PARTNERS CONTINUED TO IMPLEMENT THE PROVE IT PROJECT IN SOUTH AFRICA, RUSSIA AND BRAZIL DURING 2012. SINCE THE BEGINNING OF THE PROVE IT STUDY IN SOUTH AFRICA, THE LOCAL RESEARCH TEAM HAS ANALYZED THE RECORDS OF 652 PATIENTS WHO RECEIVED TREATMENT AT ONE OF THE STUDY SITES BETWEEN 2005-2010. DURING THE REPORTING PERIOD, THE TEAM HAS ALSO CONDUCTED A TOTAL OF 38 KEY INFORMANT INTERVIEWS WITH HEALTH OFFICIALS AS PART OF THE POLICY TRANSFER ANALYSIS TRACK OF THE STUDY. IN ADDITION TO HEALTH-FOCUSED RESEARCH, THE PROVE IT TEAM IN SOUTH AFRICA ALSO INTERVIEWED 83 PATIENTS FOR THE ECONOMIC ANALYSIS PART OF THE STUDY, WHICH AIMS TO ASCERTAIN THE FINANCIAL IMPACT OF NEW TOOLS ON PATIENTS. IN RUSSIA, THE LOCAL PROVE IT TEAM HAS ENROLLED 251 MDR-TB PATIENTS IN THE STUDY TO DATE. DURING THE REPORTING PERIOD, 74 PATIENTS PARTICIPATED IN THE SECOND PATIENT INTERVIEW, WHICH TAKES PLACE AFTER A PATIENT COST QUESTIONNAIRE WAS COMPLETED. BOTH THE RUSSIA AND SOUTH AFRICA TEAMS PRESENTED THEIR PRELIMINARY FINDINGS AT THE WORLD CONFERENCE ON LUNG HEALTH IN KUALA LUMPUR, MALAYSIA 13-17 NOVEMBER 2012. IN ADDITION TO PRESENTING THEIR WORK IN KUALA LUMPUR, THE RUSSIA STUDY TEAM ALSO GAVE A PRESENTATION AT THE ANNUAL CONGRESS OF NATIONAL TUBERCULOSIS ASSOCIATIONS IN ST. PETERSBURG, RUSSIA IN OCTOBER 2012. AS OF SEPTEMBER 2012, THE PROVE IT TEAM IN BRAZIL RECRUITED 121 PATIENTS WITH CONFIRMED TB DIAGNOSIS INTO THE LPA ARM OF THE STUDY AND 62 INTO THE XPERT MTB/RIF ARM. THEY CONTINUED TO RECRUIT PATIENTS THROUGH THE END OF THE REPORTING PERIOD. MODELLING:THE TREAT TB INITIATIVE AIMS TO PROVIDE POLICYMAKERS WITH THE INFORMATION THEY NEED TO SELECT THE MOST COST-EFFECTIVE DIAGNOSTIC TOOLS OR COMBINATION OF TOOLS THAT BEST IMPROVE PATIENT OUTCOMES AND LIMIT THE TRANSMISSION OF TUBERCULOSIS (TB) IN THEIR COMMUNITY. IN YEAR THREE, TREAT TB PARTNERS FROM THE LIVERPOOL SCHOOL OF TROPICAL MEDICINE (LSTM) AND THE HARVARD SCHOOL OF PUBLIC HEALTH/BRIGHAM AND WOMENS HOSPITAL, ALONG WITH A TECHNICAL CONSULTANT AFFILIATED WITH NATIONAL TAIWAN UNIVERSITY, WORKED TO FULFIL THIS GOAL BY DESIGNING A NOVEL MODELLING APPROACH THAT LINKS TRANSMISSION MODELLING WITH OPERATIONAL MODELLING. THE WORK COMPLETED IN 2011 PRIMARILY FOCUSED ON DRUG-SENSITIVE TB.IN YEAR FOUR, THE TREAT TB MODELLING TEAM CONDUCTED AN INITIAL EXPLORATION OF THE MODEL FOR DRUG-RESISTANT TB AND BEGAN TO RE-CALIBRATE THE MODEL FOR COUNTRIES WITH A TB EPIDEMIOLOGY DIFFERENT FROM THAT FOUND IN MALAWI AND TANZANIA, WHICH SERVED AS THE BASIS FOR THE EXISTING MODELLING APPROACH. THE TEAM WILL BUILD ON THIS WORK IN YEAR FIVE. THE MODELLING TEAM BEGAN TO USE A REVISED APPROACH TO FURTHER ASSESS XPERT MTB/RIF, A PROMISING NEW NUCLEIC ACID AMPLIFICATION TEST THAT RAPIDLY IDENTIFIES RIFAMPICIN-RESISTANT TB AND HAS THE POTENTIAL TO DECENTRALIZE DIAGNOSTIC SERVICES. XPERT MTB/RIF IS A FAR MORE EXPENSIVE TOOL THAN CURRENT ESTABLISHED APPROACHES, BUT IS HIGHLY SENSITIVE, QUICKER AND EASIER TO USE. MORE RESEARCH IS NEEDED TO DETERMINE HOW THE TEST WILL PERFORM IN DIFFERENT POPULATIONS, HEALTH SYSTEMS, AND RESOURCE-LIMITED SETTINGS. THE LINKED MODEL APPROACH HAS THE POTENTIAL TO ANSWER SOME OF THESE QUESTIONS AND WILL ASSESS THE IMPACT OF XPERT MTB/RIF ON HEALTH SYSTEM COSTS, PATIENT ACCESS AND OUTCOMES, AND THE TB EPIDEMIC IN A GIVEN SETTING. THIS WORK IS SET TO CONTINUE THROUGH THE NEXT REPORTING PERIOD. KEY RESULTS AND ACCOMPLISHMENTS: IN MAY 2012, OPERATIONAL RESEARCH ANALYST IVOR LANGLEY AND TREAT TB DEPUTY PROJECT DIRECTOR HANNAH ALSDURF TRAVELLED TO BRAZIL TO COLLECT AND ANALYZE ADDITIONAL DATA ON PATIENT OUTCOMES, COST, AND OTHER FACTORS RELATED TO THE IMPLEMENTATION OF LPA AND XPERT MTB/RIF. IN JULY 2012, IVOR LANGLEY PRESENTED TREAT TBS VIRTUAL IMPLEMENTATION APPROACH AND THE BENEFITS OF USING VIRTUAL IMPLEMENTATION FOR COST-EFFECTIVE ANALYSIS AT THE UNIONS EUROPEAN REGION CONFERENCE. IN SEPTEMBER 2012, TREAT TB PROJECT DIRECTOR DR. I.D. RUSEN AND MR. LANGLEY PRESENTED THE TREAT TB VIRTUAL IMPLEMENTATION APPROACH TO A MULTIDISCIPLINARY GROUP OF GLOBAL HEALTH PROFESSIONALS ATTENDING THE 2012 GLOBAL HEALTH MINI-UNIVERSITY, A DAYLONG EVENT DESIGNED FOR SHARING EVIDENCE-BASED BEST PRACTICES AND STATE-OF-THE-ART INFORMATION HELD EVERY YEAR IN WASHINGTON, DC. DURING THE 2012 WORLD CONFERENCE ON LUNG HEALTH IN KUALA LUMPUR, MALAYSIA, TREAT TB ORGANIZED A MODELLING-FOCUSED SYMPOSIUM FOR HEALTH POLICYMAKERS AND OTHER PUBLIC HEALTH OFFICIALS WHICH WAS ATTENDED BY APPROXIMATELY 100 PEOPLE THE TEAM ALSO FINALIZED AND DISTRIBUTED A BROCHURE SUMMARIZING THE BENEFITS AND ADVANTAGES ASSOCIATED WITH THIS MODELLING APPROACH. THE BROCHURE IS NOW AVAILABLE ON THE TREAT TB WEBSITE HERE: HTTP://TREATTB.ORG/ SYSTEMATIC REVIEWS:TREAT TB AND ITS PARTNERS AT MCGILL UNIVERSITY ARE WORKING WITH THE EDITORS OF PLOS MEDICINE TO PREPARE THE SYSTEMATIC REVIEW COMPLETED DURING THE LAST REPORTING PERIOD FOR PUBLICATION. THIS REVIEW FOCUSED ON THE METHODOLOGIC ASPECTS OF COST EFFECTIVENESS ANALYSES THAT EVALUATE INTERFERON GAMMA RELEASE ASSAYS (IGRA) FOR THE DETECTION OF LATENT TUBERCULOSIS INFECTION (LTBI). THE SYSTEMATIC REVIEW TEAM IS ALSO WORKING WITH TREAT TB PARTNERS AT THE LIVERPOOL SCHOOL OF TROPICAL MEDICINE TO CONDUCT THE ASSESSING FEASIBILITY OF IMPLEMENTING A NEW DIAGNOSTIC TEST IN RESOURCE-LIMITED SETTINGS SYSTEMATIC REVIEW, WHICH WILL BE SUBMITTED FOR PUBLICATION IN 2013.STREAMTHE UNIONS EVALUATION OF A STANDARDISED TREATMENT REGIMEN OF ANTI-TUBERCULOSIS DRUGS FOR PATIENTS WITH MULTIPLE DRUG-RESISTANT TUBERCULOSIS OR STREAM WILL SEEK TO DETERMINE WHETHER A REGIMEN DEVELOPED AND IMPLEMENTED BY THE DAMIEN FOUNDATION AND THE INSTITUTE OF TROPICAL MEDICINE, AND USED WITH NOTABLE SUCCESS IN BANGLADESH, CAN BE UTILIZED IN DIFFERENT SETTINGS WITH COMPARABLE RESULTS.THE UNION WORKED WITH LOCAL AND INTERNATIONAL PARTNERS THROUGHOUT 2012 TO MONITOR THE STUDYS PROGRESS, FACILITATED THE SHIPMENT OF SUPPLIES AND MEDICINES AS NEEDED, AND WORKED WITH COUNTRY TEAMS TO STRENGTHEN PATIENT RECRUITMENT AND RETENTION. THE UNION IS ALSO EXPLORING THE POSSIBILITY OF ADDING ADDITIONAL SITES TO THE TRIAL AND WILL UNDERTAKE A SERIES OF SITE VISITS IN THE FALL OF 2013. IN 2012, TREAT TB CONDUCTED THE FOLLOWING ACTIVITIES FOR THE STREAM CLINICAL TRIAL: BEGAN RECRUITMENT FOR THE STREAM TRIAL AT KING GEORGE V HOSPITAL IN DURBAN, SOUTH AFRICA (JUNE 2012) AND SIZWE HOSPITAL IN JOHANNESBURG, SOUTH AFRICA (AUGUST 2012). CONTINUED TO SHIP MEDICINES AND SUPPLIES TO ALL STREAM STUDY SITES AND WORK CLOSELY WITH IN-COUNTRY STUDY STAFF AS WELL AS EXTERNAL PARTNERS TO REPLENISH PHARMACEUTICALS AND MEET OTHER STREAM STUDY PROCUREMENT NEEDS ONGOINGLY. WORKED WITH IN-COUNTRY STUDY STAFF AND OFFICIALS FROM THE MINISTRY OF HEALTH AND THE ARMAUER HANSEN RESEARCH INSTITUTE (AHRI) TO PREPARE FOR THE IMPLEMENTATION OF THE STREAM STUDY AT THE SECOND SITE IN ADDIS ABABA (SCHEDULED FOR 2013). CONTINUALLY TRAINED STUDY STAFF AND PARTNERS IN GOOD CLINICAL PRACTICE AND EFFECTIVE LABORATORY METHODS, IN PARTNERSHIP WITH MRC-UK AND THE INSTITUTE FOR TROPICAL MEDICINE IN ANTWERP. HELPED PREPARE THE PHAM NGOC HOSPITAL TEAM IN HO CHI MINH CITY TO LAUNCH THE STREAM STUDY IN NOVEMBER 2012. CONDUCTING TROUBLE-SHOOTING AND FACILITATED COMMUNICATION AMONG PARTNERS THROUGHOUT THE REPORTING PERIOD. RESPONDED TO QUESTIONS FROM THE HEALTH MINISTRY OF INDIAS SCREENING COMMITTEE (HMSC) AND HELPED LOCAL PARTNERS NAVIGATE THE APPROVAL PROCESS IN INDIA. 311662 290000 STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH:THE UNION'S INTERNATIONAL MANAGEMENT PROGRAMME 2012 OVERVIEWIN ORDER TO HELP COUNTRIES IMPROVE THE MANAGEMENT OF HEALTH PROGRAMMES, THE UNION HAS DESIGNED A SERIES OF COURSES THAT ADDRESS CHALLENGES FACED BY NATIONAL PROGRAM MANAGERS AND HEALTHCARE ADMINISTRATORS IN LIMITED-RESOURCE SETTINGS. THE UNION'S INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM (IMDP) STRENGTHENS HEALTH SYSTEMS BY TRAINING HEALTH PROFESSIONALS IN SPECIFIC COMPETENCIES THAT ARE CRITICAL TO THE SUCCESS OF HEALTH PROGRAMS. THE IMDP IS ACCREDITED BY THE INTERNATIONAL ASSOCIATION FOR CONTINUING EDUCATION AND TRAINING (IACET), ONE OF THE WORLD'S LEADING ACCREDITATION AGENCIES. THE IMDP ADDRESSES KEY ISSUES SUCH AS: DEVELOPING BUDGETS FOR NATIONAL HEALTH PROGRAMMES OR INTERNATIONAL DONORS ORGANIZING AND TRAINING HEALTH STAFF ACROSS VARIOUS REGIONS AND PROVINCES COORDINATING MEDICINES AND SUPPLIES MOTIVATING OVERWORKED STAFF CREATING COMMUNICATIONS PLANS TO DISSEMINATE IMPORTANT HEALTH MESSAGES ADHERING TO STRATEGIES THAT BOOST DETECTION RATESIN 2012, THE UNIONS INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM (IMDP) TRAINED CLOSE TO 400 PARTICIPANTS FROM OVER VARIOUS COUNTRIES, INCLUDING INDONESIA, INDIA, RUSSIA, MEXICO. PROFESSIONALS SPECIALIZING IN A VARIETY OF HEALTH FIELDS ATTENDED 11+ COURSES HELD THROUGHOUT THE YEAR TO DEVELOP THEIR EXISTING SKILLS AND GAIN NEW ONES TO HELP IMPROVE THE QUALITY OF HEALTH SERVICES PROVIDED BY THE ORGANIZATIONS WHERE THEY WORK. PARTICIPANTS WERE OFFERED THE UNIQUE EXPERIENCE OF NETWORKING, SHARING EXPERIENCES AND LEARNING FROM HEALTH PROFESSIONALS IN SIMILAR FIELDS FROM AROUND THE WORLD. DURING 2012, PARTICIPANTS WERE TRAINED IN THE FOLLOWING AREAS: BUDGETING AND FINANCIAL MANAGEMENT PROJECT MANAGEMENT INFLUENCING, NETWORKING, AND PARTNERING LEADING MANAGEMENT TEAMS COMMUNICATIONS AND MASS MEDIA SUPPLY CHAIN MANAGEMENT HUMAN RESOURCES MANAGEMENTIN ADDITION TO THE COURSES, IMDP OFFERS TO ITS ALUMNI CONTINUING LEARNING THROUGH THE HEALTH MANAGER, HTTP://WWW.UNION-IMDP.ORG/HEALTH-MANAGER-RECENT-ISSUES, AN ONLINE RECURRING PUBLICATION THAT FOCUSES ON MANAGEMENT EDUCATION, SPECIFICALLY FOR HEALTH PROFESSIONALS. PLEASE READ THE HIGHLIGHTS OF THE PARTICIPANT PROFILES HERE: HTTP://WWW.UNION-IMDP.ORG/ABOUT/PARTICIPANT-PROFILES 504736 3196 PUBLIC OPINION FOR ACTION AGAINST LUNG HEALTH PROBLEMS:THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. (IUATLD) RAISES PUBLIC AWARENESS OF AND SUPPORTIVE PUBLIC OPINION FOR INCREASED DOMESTIC AND FOREIGN ASSISTANCE TO COMBAT LUNG HEALTH CHALLENGES AMONG THE POOR IN LOW AND MIDDLE INCOME COUNTRIES FROM THE UNITED STATES GOVERNMENT, PRIVATE CHARITIES, FOUNDATIONS AND OTHER DONORS.EDUCATION AND TRAINING:IUATLD, INC. ORGANIZES AND/OR SUPPORTS IMPORTANT INTERNATIONAL CONFERENCES AND TRAINING PROGRAMS CONFERENCES AND TRAININGS ON TUBERCULOSIS, TOBACCO CONTROL, ASTHMA AND LUNG HEALTH AND WORKS TO INCREASE THE PARTICIPATION OF DOCTORS, NURSES, AND ALLIED HEALTH PERSONNEL FROM LOW AND MIDDLE INCOME COUNTRIES THROUGH THE PROVISION OF TECHNICAL SUPPORT, SCHOLARSHIPS AND TRAVEL GRANTS.PROJECT MANAGEMENT:IUATLD, INC. DIRECTLY MANAGES AND COORDINATES CAPACITY BUILDING, TECHNICAL ASSISTANCE AND RESEARCH PROJECTS FUNDED BY GOVERNMENTAL AND NON-GOVERNMENTAL DONORS IN COLLABORATION WITH MINISTRIES OF HEALTH AND NON-GOVERNMENTAL PARTNERS IN LOW AND MIDDLE INCOME COUNTRIES. THE UNION CONSIDERS ALL POTENTIAL PROJECTS AND DONATIONS IN THE CONTEXT OF OUR GUIDING VALUES: QUALITY (CAN WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST ATTAINABLE STANDARDS?); ACCOUNTABILITY (CAN WE DEMONSTRATE RESPONSIBLE STEWARDSHIP OF RESOURCES AND DELIVER AND REPORT ON OUR COMMITMENTS?); INDEPENDENCE (DO WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION AND SEEK EVIDENCE TO IMPROVE HEALTH AND MANAGEMENT SYSTEMS?); AND SOLIDARITY (CAN WE STAND TOGETHER TO OVERCOME GREAT CHALLENGES AND ACHIEVE BETTER HEALTH AMONG THE COMMUNITIES WE SERVE AND IN PARTICULAR FOR THE POOR?) 504736 3196 18394336 1 1 0 0 0 0 0 0 1 0 1 0 0 1 0 1 1 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 36 0 6 1 0 0 0 0 0 0 0 0 0 0 X 8 6 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 1 0 IL NJ NY X X MILI CHOWFLA 2125005738 61 BROADWAY SUITE 1720 NEW YORK NY 10006 JOSE LUIS CASTRO 10.00 30.00 X X 0 100385 4015 PETER BALDINI 1.00 40.00 X X 0 325000 27669 MARIO PIERRO 1.00 X 0 0 0 NILS BILLO 1.00 3.00 X X 0 0 0 DEAN SCHRAUFNAGEL 1.00 X 0 0 0 MASAE KAWAMURA 1.00 X 0 0 0 SCOTT HALSTEAD 1.00 X X 0 0 0 SAMIDH GUHA 1.00 X 0 0 0 PAULA FUJIWARA 40.00 3.00 X 250000 0 25642 250000 425385 57326 1 0 1 0 SYLVIANE RATTE 4 RUE LE BRUN PARIS FR 75013 INTL TOBACCO CONTROL CONSULTING SVCS 100188 1 13289408 3607513 1703103 18600024 5102 5102 18605126 0 0 5102 285160 285160 16385426 16385426 289699 289699 375797 353343 22454 8468 7570 898 52004 50532 1472 34795 32705 2090 12468 12468 57057 28586 28471 388593 382664 5929 51352 51352 57837 57837 201757 201757 163686 156468 7218 56859 56859 1720 1720 22579 22579 EQUIP RENTAL & REPAIR 15035 15035 RELOCATION EXPENSE 12252 12252 OTHER EXPENSES 7980 423 7557 STAFF DEVLPMT & RECRUIT 2153 2153 18482677 18394336 88341 0 1786624 418532 60171 271529 6908116 4954765 8333 7169 5448 2242 1721 807493 1265840 9564646 6920720 76135 141154 7278086 5590367 1378196 234522 8732417 5966043 X 32799 58565 799430 896112 832229 954677 9564646 6920720 122449 0 X X 0 1 X 1 1 1 X 5279 19419094 20284523 24925400 18607024 83241320 5279 19419094 20284523 24925400 18607024 83241320 67356981 15884339 88 11877 12005 1246 5102 30318 221 11608 11829 83283467 0.19070 0.90260 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2010 AMOUNT: $ 221. 2012 AMOUNT: $ 11,608. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 X 7169 5448 1721 1721 DUE FROM AFFILIATE - IUATLD, INC. (PARIS) 1265840 1265840 X 18605126 0 18605126 0 18605126 18482677 0 18482677 0 18482677 PART IV, LINE 2B: THE INTERNATIONAL UNION AGAINST TUBERCULOSIS & LUNG DISEASE (IUATLD) IS ACTING AS FIDUCIARY FISCAL AGENT FOR THE NORTH AMERICAN REGION (NAR) CONFERENCE. THESE FUNDS ARE USED FOR NAR-RELATED EXPENSES AND ARE FURNISHED UPON REQUEST TO THE BRITISH COLUMBIA LUNG ASSOCIATION. THESE FUNDS REPRESENTED THE BALANCE OF ALL NAR NET PROCEEDS THROUGH JANUARY 31, 2011. THESE AMOUNTS WERE PREVIOUSLY MAINTAINED BY THE AMERICAN LUNG ASSOCIATION OF THE UPPER MIDWEST AS THE SECRETARIAT. THE SECRETARIAT ROLE INCLUDED DUTIES AS SECRETARY OF THE ANNUAL CONFERENCE AND FIDUCIARY FISCAL AGENT FOR THE CONFERENCE. THE SECRETARIAT RELATIONSHIP HAS ENDED AND THE FUND BALANCE WAS REMITTED TO THE IUATLD. ALL ADDITIONAL FUNDS DIRECTED TO THE AMERICAN LUNG ASSOCIATION ARE TRANSFERRED TO THE IUATLD WHEN RECEIVED. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: IUATLD, INC. RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE IUATLD, INC. HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. IUATLD, INC. IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR PERIODS PRIOR TO 2009. 1 EUROPE 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 11279266 ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 2118827 AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 1307158 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 11966 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 976368 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 599608 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION FOR TOBACCO CONTROL 92233 0 0 0 0 0 0 16385426 0 16385426 EUROPE BLOOMBERG INITIATIVE TO REDUCE TOBACCO USE 11279266 WIRE TRANSFER N/A N/A ASIA TO CONDUCT INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM COSTS 2118827 WIRE TRANSFER N/A N/A AFRICA TO REDUCE TOBACCO USE AND CONDUCT STRATEGIC HEALTH INFO.AND OPERATIONAL RESEARCH 1307158 WIRE TRANSFER N/A NORTH AMERICA TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS 11966 WIRE TRANSFER N/A SOUTH AMERICA TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS 976368 WIRE TRANSFER N/A SOUTH ASIA TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS 599608 WIRE TRANSFER N/A RUSSIA & THE NEWLY INDEPENDENT STATES TO REDUCE TOBACCO USE AND TREAT TUBERCULOSIS 92233 WIRE TRANSFER N/A 53 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: IUATLD, INC. IS BOTH A RECIPIENT AND ISSUER OF GRANT FUNDING. THE ORGANIZATION MAINTAINS A GRANT FUNDING MONITORING SYSTEM TO EFFECTIVELY MONITOR AND REPORT RESULTS OF GRANT FUNDING ISSUED TO RECIPIENTS. THIS SYSTEM FEATURES A STANDARDIZED GRANTS FUNDING AGREEMENT AND REPORTING FORMAT. VARIOUS IUATLD, INC. STAFF ARE INVOLVED IN THE SYSTEM ESTABLISHED TO ISSUE AND MONITOR GRANT FUNDS. THIS INCLUDES THE FINANCE AND OPERATIONS OFFICER, WHO OVERSEES THE PROCESS TO ISSUE GRANT FUNDING AGREEMENTS, AND THE RESEARCH AND EVALUATION COORDINATOR WHO OVERSEES DAY TO DAY MANAGEMENT OF INFORMATION RELATED TO RECIPIENT PROGRESS AND REPORTS. METHOD USED TO ACCCOUNT FOR EXPENDITURES: SCHEDULE F, PART I, LINE 3: EXPENDITURES ARE RECOGNIZED UNDER THE ACCRUAL BASIS OF ACCOUNTING. 1 BRIGHAM & WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 31478 TREAT TB PROGRAM ENCOMPASS LLC 11461 ROCKVILLE PIKE SUITE 229 ROCKVILLE MD 20582 522228651 N/A 38492 TREAT TB PROGRAM WORLD LUNG FOUNDATION 61 BROADWAY SUITE 2800 NEW YORK NY 10006 202432410 501(C)(3) 215190 TOBACCO CONTROL RUSSIA 2 1 SCHEDULE I, PART I, LINE 2 THE SUB-GRANTESS ARE REQUIRED TO SUBMIT QUARTERLY FINANCIAL REPORTS AND NARRATIVES TO PROJECT MANAGERS. VARIANCES FROM THE APPROVED BUDGET ARE SCRUTINIZED AND EXPLAINED. ORGANIZATION ALSO REQUEST THE ANNUAL FINANCIAL STATEMENT AND AUDITOR'S REPORT FROM SUB-GRANTEES. PROJECT MANAGER CONDUCTS INTERNAL AUDIT ON-SITE WHEN NEEDED. 0 0 0 0 0 0 0 0 0 PETER BALDINI 0 300000 0 25000 0 0 0 2400 0 25269 0 352669 0 0 PAULA FUJIWARA 250000 0 0 0 0 0 10000 0 15642 0 275642 0 0 0 PART I, LINE 3 COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR IS PAID BY THE WORLD LUNG FOUNDATION, A SUPPORTING ORGANIZATION, USING THE FOLLOWING PROCESS TO DETERMINE EXECUTIVE COMPENSATION: A. THE PERSONNEL/COMPENSATION COMMITTEE OF THE BOARD ESTABLISHES THE SALARY OF THE CHIEF EXECUTIVE OFFICER AND ESTABLISHES THE GUIDELINES FOR ALL REMAINING STAFF. B. THE PERSONNEL/COMPENSATION COMMITTEE'S DETERMINATION IS BASED ON SEVERAL FACTORS PROVIDED BY A STUDY DONE BY A COMPENSATION CONSULTING FIRM, THOSE FACTORS ARE AS FOLLOWS: 1. INTERNAL EQUITY 2. EQUITY WITH EXTERNAL ORGANIZATIONS SIMILAR TO WLF 3. MARKET ANALYSIS/SALARY RANGES 4. BENEFITS ANALYSIS 5. PERFORMANCE MANAGEMENT & REWARD SYSTEM 6. SALARY ADMINISTRATION 7. INCENTIVE COMPENSATION TWO OTHER MAIN FACTORS WILL DETERMINE THE FINAL DECISION ON INCREASES: 1. ECONOMIC SITUATION 2. THE PROPOSED BUDGET FOR THE NEXT FISCAL YEAR C. THE PERSONNEL/COMPENSATION COMMITTEE ALONG WITH THE COMPENSATION CONSULTING FIRM'S NEXT REVIEW IS DUE IN SEPTEMBER 2013. THE LAST REVIEW WAS IN SEPTEMBER 2009. FORM 990, PART VI, SECTION A, LINE 2 MR. PETER BALDINI, MR JOSE LUIS CASTRO, PAULA I.FUJIWARA AND MR. NILS BILLO HAVE A BUSINESS RELATIONSHIP. ALL OF THESE PERSONS SERVE IN DIFFERENT CAPACITIES ON THE BOARDS OF RELATED ORGANIZATIONS. MR. BALDINI SERVES AS THE EXECUTIVE DIRECTOR OF WORLD LUNG FOUNDATION (WLF). MR BILLO ALSO SERVES AS THE EXECUTIVE DIRECTOR IUATLD, INC, PARIS. FORM 990, PART VI, SECTION B, LINE 11 IUATLD, INC. HAS ITS FORM 990 PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. WHEN THE FORM 990 HAS BEEN PREPARED, REVIEWED BY MANAGEMENT AND IS READY TO BE FILED WITH THE INTERNAL REVENUE SERVICE, IT IS SUBMITTED ELECTRONICALLY TO MEMBERS OF THE IUATLD, INC. BOARD OF DIRECTORS FOR ANY COMMENTS PRIOR TO ITS SUBMISSION. THE BOARD OF DIRECTORS IS PROVIDED ONE WEEK TO REVIEW THE PREPARED FORM 990, TO CONSULT WITH MANAGEMENT, AND TO PROVIDE THEIR COMMENTS. ANY COMMENTS RECEIVED ARE THEN GROUPED, SUMMARIZED AND PROVIDED TO THE COMMITTEE IN CHARGE OF FILING THE RETURN FOR THEIR REVIEW AND ACTION. EACH ISSUE IS DOCUMENTED AND ADDRESSED UNTIL THE RETURN IS FINALIZED AND APPROVED FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C IUATLD, INC. HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT ANNUALLY MONITORS AND ENFORCES. THE BOARD OF DIRECTORS MANDATES THAT ALL MEMBERS OF MANAGEMENT AND THE GOVERNING BODY ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED POLICIES ARE SUBMITTED TO THE EXECUTIVE DIRECTOR (WHO CURRENTLY SERVES AS THE ORGANIZATION'S COMPLIANCE OFFICER) WHO REVIEWS THE SIGNED ATTESTATIONS FOR POTENTIAL OR ACTUAL CONFLICTS. (IN THE ABSENCE OF A DEDICATED COMPLIANCE OFFICER, THE PRESIDENT OF THE BOARD OF DIRECTORS CURRENTLY PERFORMS THIS FUNCTION FOR THE POLICY SUBMITTED BY THE EXECUTIVE DIRECTOR). IF POTENTIAL OR ACTUAL CONFLICTS OF INTEREST EXIST, PROPER NOTIFICATIONS ARE MADE, AND RESULTS OF INVESTIGATIONS ARE SUMMARIZED AND REPORTED TO THE BOARD OF DIRECTORS. IF ACTUAL CONFLICTS EXIST, THE INDIVIDUAL(S) INVOLVED ARE NOT ALLOWED TO VOTE OR BE A PART OF ANY DECISIONS ABOUT ANY SUCH TRANSACTIONS THAT RELATE TO THE CONFLICT UNTIL SUCH TIME AS THERE IS NO LONGER A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15B IUATLD, INC. HAS ESTABLISHED A WRITTEN COMPENSATION POLICY TO BE FOLLOWED BY MANAGEMENT AND, WHEN NECESSARY, THE BOARD OF DIRECTORS IN ORDER TO ESTABLISH THE COMPENSATION FOR THE EXECUTIVE DIRECTOR AND OTHER KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE-LEVEL COMPENSATION BE PERIODICALLY REVIEWED BY MANAGEMENT AND THE BOARD OF DIRECTORS AND THAT THE REVIEW PROCESS SHOULD BE FREE OF POTENTIAL CONFLICTS OF INTEREST. THE APPROVING ENTITY NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF COMPENSATION BEING CONSIDERED. A VARIETY OF INFORMATION AND COMPARABILITY DATA ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO EXECUTIVES. THESE INCLUDE SURVEYS OF NEW YORK CITY-BASED NON-PROFIT COMPENSATION PRACTICES, COMPARABLE PACKAGES FOR KEY STAFF OF PEER ORGANIZATIONS, AND COMPENSATION PRACTICES EXPECTED BY PROJECT DONORS. DECISIONS TAKEN ON COMPENSATION LEVELS TO BE PAID MUST BE DOCUMENTED IN WRITTEN FORM TO INCLUDE THE DATES DECISIONS ARE TAKEN, THE PARTIES PRESENT DURING THE DECISION, THE FULL TERMS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. THE COMPENSATION REVIEW PROCESS FOR THE EXECUTIVE DIRECTOR AND SENIOR ADVISOR POSITIONS WAS UNDERTAKEN IN JANUARY 2009. THE EXECUTIVE DIRECTOR'S COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS IN ADDITION TO THE ONES DESCRIBED ABOVE, INCLUDING COMPARABLE COMPENSATION LEVELS FOR A) NEW YORK CITY-BASED EXECUTIVES OVERSEEING NOT FOR PROFIT ORGANIZATIONS AND AFFILIATE OFFICES OF INTERNATIONAL ORGANIZATIONS, B) PUBLIC HEALTH PROFESSIONALS WITH 15-20 YEARS EXPERIENCE IN PROJECT MANAGEMENT, PARTNERSHIPS AND OPERATIONS AND LASTLY THE SALARY EXPECTATIONS OF KEY DONORS TO IUATLD, INC.-COORDINATED PROJECTS. THE SENIOR ADVISORS COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS INCLUDING COMPARABLE COMPENSATION LEVELS FOR U.S. BASED MEDICAL DOCTORS WHO A) HAVE A VERY HIGH LEVEL OF CLINICAL EXPERIENCE IN THE TREATMENT, CONTROL AND PREVENTION OF TUBERCULOSIS AND HIV/AIDS, B) HAVE AT LEAST TWENTY YEARS OF EXPERIENCE IN MANAGING COMPLEX PUBLIC HEALTH PROGRAMS, INTERNATIONAL RESEARCH PROJECTS AND INTERNATIONAL TECHNICAL ASSISTANCE PROJECTS IN DEVELOPING COUNTRY SETTINGS AND C) HAVE DEEP EXPERIENCE IN WORKING WITH U.S. GOVERNMENT TECHNICAL AGENCIES AND DONORS INVOLVED IN GLOBAL LUNG HEALTH INITIATIVES. FORM 990, PART VI, SECTION C, LINE 19 IUATLD, INC. MAKES ITS FORM 990 AND FORM 1023 AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE SERVICE CODE BY POSTING IT TO GUIDESTAR AND OTHER SIMILAR TYPES OF WEBSITES. IN ADDITION, ALL FORMS 990, AS WELL AS FINANCIAL STATEMENTS, THE CONFLICT OF INTEREST POLICY AND OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST AT IUATLD, INC. OFFICES LOCATED AT 61 BROADWAY, SUITE 1720, NEW YORK, NY 10006 OR BY CALLING THE ORGANIZATION DIRECTLY AT (212) 500-5720. OVERSIGHT OF THE AUDIT OF THE FINANCIAL STATEMENTS AND ACCOUNTANT SELECTION FORM 990, PART XI, LINE 2C: THIS PROCESS DID NOT CHANGE FROM THE PRIOR YEAR. ALTHOUGH, IUATLD, INC. DOES NOT HAVE ANY AUDIT COMMITTEE, THE GOVERNING BODY ACTS IN THAT CAPACITY AND MAKES ALL DECISIONS. A-133 AUDIT FOR 2012 OCCURED ON SEPTEMBER 30, 2013. WORLD LUNG FOUNDATION 61 BROADWAY NEW YORK NY 10006 202432410 TOBACCO REDUCTION/HEALTH RESEARCH INITIATIVE NY 501(C)(3) 509(A)(3) INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE INC 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 WORLD LUNG FOUNDATION O 431804 COST WORLD LUNG FOUNDATION C 13289408 CASH